NCT03937102View on ClinicalTrials.gov

Measurement of Cardiac Output in Intensive Care Unit With Unstable Hemodynamic: Validation of Physioflow® Device Versus Trans Thoracic Echocardiography

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

April 25, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Cardiac Output
Interventions
PROCEDURE

cardiac output measure with TTE

All patients included will be simultaneously monitored with transthoracic echocardiography (TTE) and the Physioflow® thoracic electrical bioimpedance device. Cardiac output is measured by the Physioflow® Thoracic Bioimpedance Device and TTE before and after passive leg raising maneuver (PLR)

PROCEDURE

cardiac output measure with Physioflow® thoracic electrical bioimpedance

All patients included will be simultaneously monitored with transthoracic echocardiography (TTE) and the Physioflow® thoracic electrical bioimpedance device. Cardiac output is measured by the Physioflow® Thoracic Bioimpedance Device and TTE before and after passive leg raising maneuver (PLR)

Trial Locations (1)

80480

CHU Amiens, Amiens

All Listed Sponsors
collaborator

Centre Hospitalier de Lens

OTHER

lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03937102 - Measurement of Cardiac Output in Intensive Care Unit With Unstable Hemodynamic: Validation of Physioflow® Device Versus Trans Thoracic Echocardiography | Biotech Hunter | Biotech Hunter